Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Reischl

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
The Prostate|August 6, 2010
High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMAKaren Alt, Stefan Wiehr, Walter Ehrlichmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 25, 2010
Increased [11C]PIB-PET levels in inclusion body myositis are indicative of amyloid beta depositionWalter Maetzler, Matthias Reimold, Jens Schittenhelm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapySusanne-Martina Eschmann, Frank Paulsen, Matthias Reimold, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 4, 2012
Microfluidic reactor geometries for radiolysis reduction in radiopharmaceuticalsChristian Rensch, Bjoern Waengler, Andriy Yaroshenko, et al.
Journal of Visualized Experiments : Jove|May 19, 2017
Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CTSabrina H L Hoffmann, Andreas Maurer, Dorothea I Reck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2002
Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PETSusanne M Eschmann, Gerald Reischl, Kilian Bilger, et al.
Inflammopharmacology|May 1, 2019
Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritisPhilipp Guenthoer, Kerstin Fuchs, Gerald Reischl, et al.
Acta Oncologica (Stockholm, Sweden)|October 21, 2015
Robustness of quantitative hypoxia PET image analysis for predicting local tumor controlDavid Mönnich, Stefan Welz, Daniela Thorwarth, et al.
Cancers|November 27, 2024
PSMA-Guided Imaging and Therapy of Advanced Adenoid Cystic Carcinomas and Other Salivary Gland CarcinomasNils F Trautwein, Andreas Brendlin, Gerald Reischl, et al.
Cancer Research|March 26, 2009
Noninvasive imaging of alphaVbeta3 function as a predictor of the antimigratory and antiproliferative effects of dasatinibRebecca A Dumont, Isabel Hildebrandt, Helen Su, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
The Prostate|August 6, 2010
High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMAKaren Alt, Stefan Wiehr, Walter Ehrlichmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 25, 2010
Increased [11C]PIB-PET levels in inclusion body myositis are indicative of amyloid beta depositionWalter Maetzler, Matthias Reimold, Jens Schittenhelm, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapySusanne-Martina Eschmann, Frank Paulsen, Matthias Reimold, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 4, 2012
Microfluidic reactor geometries for radiolysis reduction in radiopharmaceuticalsChristian Rensch, Bjoern Waengler, Andriy Yaroshenko, et al.
Journal of Visualized Experiments : Jove|May 19, 2017
Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CTSabrina H L Hoffmann, Andreas Maurer, Dorothea I Reck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2002
Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PETSusanne M Eschmann, Gerald Reischl, Kilian Bilger, et al.
Inflammopharmacology|May 1, 2019
Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritisPhilipp Guenthoer, Kerstin Fuchs, Gerald Reischl, et al.
Acta Oncologica (Stockholm, Sweden)|October 21, 2015
Robustness of quantitative hypoxia PET image analysis for predicting local tumor controlDavid Mönnich, Stefan Welz, Daniela Thorwarth, et al.
Cancers|November 27, 2024
PSMA-Guided Imaging and Therapy of Advanced Adenoid Cystic Carcinomas and Other Salivary Gland CarcinomasNils F Trautwein, Andreas Brendlin, Gerald Reischl, et al.
Cancer Research|March 26, 2009
Noninvasive imaging of alphaVbeta3 function as a predictor of the antimigratory and antiproliferative effects of dasatinibRebecca A Dumont, Isabel Hildebrandt, Helen Su, et al.
Pageof 11